30 April 2020 - AstraZeneca agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race heats up for the key to halting the pandemic.

The company is one of dozens around the world that have joined the competition, with the Trump administration on Wednesday announcing a massive effort aimed at making shots available for Americans by year's end. 

Astra's tie-up with Oxford shows how developers are aiming to manufacture vaccines before they've cleared human tests so they can be distributed as soon as possible.

Read Sydney Morning Herald article